Salman Al-Mahmood
Plus aucun poste en cours
Profil
Salman Al-Mahmood was a former Chief Scientific Officer at Gene Signal International SA, where he worked from 2000 to 2010.
He founded Gene Signal International SA in 2000.
Dr. Al-Mahmood has a graduate and doctorate degree from Université Nancy II.
Anciens postes connus de Salman Al-Mahmood
| Sociétés | Poste | Fin |
|---|---|---|
Gene Signal International SA
 Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Fondateur | - |
Formation de Salman Al-Mahmood
| Université Nancy II | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
